Coronavirus - Page 7
Covaxin phase III clinical trials show 77.8% efficacy
The phase III clinical trials of Bharat Biotechās Covaxin showed 77.8 per cent efficacy, said media reports on Tuesday citing sources.
By Newsmeter Network Published on 22 Jun 2021 6:00 PM IST
Is loss of taste and smell among COVID patients related to brain?
There has been extensive evidence of brain-related pathologies associated with COVID-19 disease throughout the pandemic, even asymptomatic cases...
By Newsmeter Network Published on 18 Jun 2021 1:23 PM IST
Vaccines protected 95 % of healthcare workers, only 4.28 % got post-inoculation infection: Apollo study
Post-vaccination infection occurred in only 4.28 per cent which is 1,355 out of 31,621 of the vaccinated healthcare workers
By Newsmeter Network Published on 17 Jun 2021 8:40 AM IST
COVID Delta variant in youth: look out for headache, sore throat as major symptoms
Loss of smell no longer appears to be the most common symptom for COVID Delta variant, according to Zoe Covid Symptom study, a UK-based Covid research...
By Newsmeter Network Published on 16 Jun 2021 2:13 PM IST
Central panel confirms first death due to COVID-19 vaccine in India
A 68-year-old man died due to anaphylaxis after he was administered Covishield on 8 March.
By Newsmeter Network Published on 15 Jun 2021 4:20 PM IST
Complex manufacturing process, cost of raw materials behind Covaxin cost: Bharat Biotech
The supply price of Covaxin at Rs 150 per dose to the government of India is a non-competitive price and clearly not sustainable in the long run....
By Newsmeter Network Published on 15 Jun 2021 4:01 PM IST
Globally over 50% women lost employment due to pandemic
Globally, 54 per cent of women lost their jobs during the COVID-19 pandemic, said Columbia University Medical Centre Public Psychiatry Education...
By Newsmeter Network Published on 13 Jun 2021 11:19 AM IST
CSIR, Laxai Life Sciences get nod to conduct clinical trials of colchicine on COVID-19 patients
The partner CSIR institutes in this clinical trial are the CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, and the CSIR-Indian...
By Newsmeter Network Published on 12 Jun 2021 4:59 PM IST
9 studies on safety, efficacy of Covaxin published in 12 months: Bharat Biotech
Facing criticism about the clinical data of Covaxin, Hyderabad-based Bharat Biotech on Saturday said the complete data for Phase I and II, and partial...
By Newsmeter Network Published on 12 Jun 2021 4:44 PM IST
Treatment guidelines for COVID positive kids: Here is list of dos and don'ts
Union Ministry of Health has issued clinical guidelines for the treatment of COVID-positive children amid concerns that a possible third wave may...
By Newsmeter Network Published on 10 Jun 2021 10:06 AM IST
Covishield at Rs 780, Covaxin at Rs 1410, Sputnik V at Rs 1145 ; Centre caps vaccine price at pvt hospitals
The Union Health Ministry on Tuesday fixed the maximum rates of Covid vaccines for the private hospitals.
By Newsmeter Network Published on 8 Jun 2021 9:39 PM IST
No data to show subsequent COVID waves will target children: AIIMS director
Dr Randeep Guleria, director of All India Institute of Medical Sciences (AIIMS) Delhi said that there is no data to show that children will be...
By Newsmeter Network Published on 8 Jun 2021 8:03 PM IST
